Y. Sato

发表

Differential contribution of two serine residues of wild type and constitutively active β2‐adrenoceptors to the interaction with β2‐selective agonists

H. Kikkawa, T. Nagao, H. Kurose, 1997, British journal of pharmacology.

Desensitization and selective down-regulation of rat cardiac beta 1-adrenoceptors by prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor full agonist.

T. Nagao, K. Imai, P. Prados, 1995, Japanese journal of pharmacology.

Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.

T. Nagao, H. Kurose, Y. Sato, 1997, Japanese journal of pharmacology.

Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.

T. Nagao, H. Kurose, M. Isogaya, 1996, European journal of pharmacology.

Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.

M. Hirobe, Y. Sato, I. Takayanagi, 1985, General pharmacology.

Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut.

Y. Sato, M. Ishikawa, F. Konno, 1998, Journal of medicinal chemistry.

Distinct Effects of Z-335, a New Thromboxane A2 Receptor Antagonist, on Rabbit Platelets and Aortic Smooth Muscle

N. Nakahata, S. Ohkubo, Y. Sato, 2006, Pharmacology.

Pharmacological properties of a new centrally acting muscle relaxant (NC-1200) in isolated muscle preparations.

Y. Sato, I. Takayanagi, F. Konno, 1988, General pharmacology.

Sensitive determination of (-)-isoproterenol and (-)-(R)-1-(3,4- dihydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino] ethanol (T-0509), a cardiotonic agent, in rat plasma utilizing a fully automated catecholamine analyser.

K. Imai, T. Nagao, P. Prados, 1994, Biomedical chromatography : BMC.

Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.

M. Hosono, N. Taira, K. Nunoki, 1988, Japanese journal of pharmacology.

A new 5-HT3 receptor ligand. II. Structure-activity analysis of 5-HT3 receptor agonist action in the gut.

Y. Sato, K. Kobayashi, F. Konno, 1998, Chemical & pharmaceutical bulletin.